Allotment is out. Check your result on the Invicta Diagnostic SME IPO Allotment Status page.
Invicta Diagnostic SME logo

Invicta Diagnostic SME IPO Subscription Status

|Alloted

Invicta Diagnostic SME IPO closed on 3 December 2025 with an overall subscription of 4.27x based on shares applied. QIB demand came in at 3.51x, NII at 7.27x, and retail at 3.44x.

Allotment will be finalised on 4 December 2025. The stock is scheduled to list on NSE and BSE on 8 December 2025.

Issue Price

Rs 85.00

GMP Today

-

Overall Subscription

4.27x

Issue Size

₹28.12 Cr

Allotment Date

4 Dec 2025

Listing Date

8 Dec 2025

Invicta Diagnostic SME IPO Subscription by Amount

Category-wise subscription based on amount applied at issue price Rs 85.00

CategoryAmount OfferedAmount AppliedSubscription
QIBRs 4.54 CrRs 15.94 Cr3.51x
FII---
DFI---
Mutual Funds---
Other-Rs 15.94 Cr-
NIIRs 4.61 CrRs 33.50 Cr7.27x
bNII (above Rs 10L)Rs 3.07 CrRs 23.85 Cr7.76x
Corporate-Rs 1.96 Cr-
Individual-Rs 21.90 Cr-
Other---
sNII (Rs 2L to Rs 10L)Rs 1.54 CrRs 9.64 Cr6.27x
Corporate-Rs 28.56 L-
Individual-Rs 9.23 Cr-
Other-Rs 12.24 L-
INDRs 10.77 CrRs 37.07 Cr3.44x
TotalRs 19.92 CrRs 86.51 Cr4.34x

Invicta Diagnostic SME IPO Subscription by Applications

Category-wise subscription based on applications received

CategoryApplications OfferedApplications ReceivedSubscription
QIB33430.01x
FII---
DFI---
Mutual Funds---
Other-3-
NII1134073.60x
bNII (above Rs 10L)751892.52x
Corporate-6-
Individual-183-
Other---
sNII (Rs 2L to Rs 10L)382185.74x
Corporate-7-
Individual-208-
Other-3-
IND3961,3633.44x
Total8431,7732.10x

What Do These Subscription Numbers Mean?

A subscription of 4.27x by shares means the IPO received bids for 4 times the shares reserved. Allotment odds depend on application count in each category, not share volume.

Here is what each category number tells you:

QIB at 3.51x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 3.51x, it reflects serious institutional conviction.

NII at 3.60x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 2.52x and sNII at 5.74x by applications. Share subscription was 7.27x. Allotment uses application count, not share volume.

At 3.44x subscription by applications, approximately 1 in 3 retail applicants can expect an allotment (~29% per application). Retail allotment is done by lottery when oversubscribed.

Invicta Diagnostic SME IPO Allotment Chances

Allotment odds below use application subscription (number of bids received), not share or amount subscribed.

Retail (IND)

  • Application subscription: 3.44x.
  • Allotment odds: about 1 in 3 (~29% chance per application).
  • Method: Lottery. If allotted, you receive at least one lot.
  • One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.

SHNI (Rs 2 lakh to Rs 10 lakh)

  • Application subscription: 5.74x.
  • Allotment odds: about 1 in 6 for a minimum-lot application (~17% of the applied lot on average).
  • Method: Proportional. Shares allotted are based on your bid size, not a lottery.
  • Share subscription was 6.27x. Allotment uses application count, not share volume.

BHNI (above Rs 10 lakh)

  • Application subscription: 2.52x.
  • Allotment odds: about 1 in 3 for a minimum-lot application (~40% of the applied lot on average).
  • Method: Proportional. Shares allotted are based on your bid size, not a lottery.
  • Share subscription was 7.76x. Allotment uses application count, not share volume.

Check the Invicta Diagnostic SME IPO Allotment Status page from 4 December 2025 for your allotment result.

Invicta Diagnostic SME IPO Day-wise Subscription

DayQIBNIIRetailOverall
Day 1 - 1 Dec 20251.00x0.68x0.29x0.54x
Day 2 - 2 Dec 20251.55x0.74x0.79x0.95x
Day 3 - 3 Dec 20253.51x6.96x3.44x4.27x

Invicta Diagnostic SME IPO Key Dates

EventDate
IPO Open Date1 December 2025
IPO Close Date3 December 2025
Allotment Date4 December 2025
Refund Initiation5 December 2025
Share Credit to Demat5 December 2025
Listing Date8 December 2025
Minimum InvestmentRs 2,72,000.00
Lot Size1600 shares

About Invicta Diagnostic SME

Invicta Diagnostics (PC Diagnostics) is a diagnostic chain operating primarily in the Mumbai Metropolitan Region (MMR). The company provides a one-stop solution by offering both radiology (X-ray, CT, MRI, PET CT) and pathology (routine and specialized tests) services through a hub-and-spoke model. The network includes 7 diagnostic centres and 1 centralised laboratory across MMR, ensuring high-end services are accessible.

Understanding Subscription Categories

QIB - Qualified Institutional Buyers

Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.

NII - Non-Institutional Investors

High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.

IND - Individual Investors

Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.

Advertisement

Invicta Diagnostic SME IPO Subscription FAQs

What is Invicta Diagnostic SME IPO subscription status today?

Invicta Diagnostic SME IPO subscription closed on 3 December 2025 with overall subscription of 4.27x (by shares) as of 27 June 2026, 3:17 AM IST. QIB 3.51x, NII 3.60x, IND 3.44x.

What is the overall subscription of Invicta Diagnostic SME IPO?

Invicta Diagnostic SME IPO is subscribed 4.27x overall by shares at close on 3 December 2025. QIB 3.51x, NII 3.60x, and IND 3.44x.

What is Invicta Diagnostic SME IPO QIB subscription?

Invicta Diagnostic SME IPO QIB (Qualified Institutional Buyers) subscription is 3.51x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.

What is Invicta Diagnostic SME IPO IND subscription?

Invicta Diagnostic SME IPO IND subscription is 3.44x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.

What is Invicta Diagnostic SME IPO NII subscription?

Invicta Diagnostic SME IPO NII (Non-Institutional Investors) subscription is 3.60x by applications. NII covers bids above Rs 2 lakh.

What are allotment chances in Invicta Diagnostic SME IPO for retail?

At 3.44x subscription by applications, approximately 1 in 3 retail applicants can expect an allotment (~29% per application). Allotment is done by lottery.

When is Invicta Diagnostic SME IPO allotment date?

Invicta Diagnostic SME IPO allotment date is 4 December 2025. Check Invicta Diagnostic SME IPO Allotment Status on IPOwiz from that day using your PAN.

When does Invicta Diagnostic SME IPO subscription close?

Invicta Diagnostic SME IPO subscription closed on 3 December 2025. No new applications are accepted after the close.

What is Invicta Diagnostic SME IPO GMP today?

GMP for Invicta Diagnostic SME IPO is not available yet. Track Invicta Diagnostic SME IPO GMP Today on IPOwiz once grey market activity starts.

What is Invicta Diagnostic SME IPO issue price and lot size?

Invicta Diagnostic SME IPO issue price is ₹85 per share. Lot size is 1600 shares. Minimum investment is ₹2,72,000 per lot (minimum 2 lots for SME). Issue size: ₹28.12 Cr.

When is Invicta Diagnostic SME IPO listing date?

Invicta Diagnostic SME IPO listing date is 8 December 2025 on NSE and BSE. Allotment is on 4 December 2025.

How does subscription affect Invicta Diagnostic SME IPO allotment?

Allotment odds in Invicta Diagnostic SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII proportional allotment at 3.60x by applications means roughly 1 in 4 for minimum-lot bids; bNII at 2.52x (~1 in 3). At 4.27x overall, competition is moderate.

For allotment results from 4 December 2025, visit the Invicta Diagnostic SME IPO Allotment Status page. For listing day updates on 8 December 2025, download the IPOwiz App.

Reviewed by Dinesh Agrawal

15+ years in Indian capital markets and IPO research. Subscription data verified before publish.